جست‌وجوی استاد و پژوهشگر

Allyson Friedmanمشاهده پروفایل

دانشیار

• Cellular Neurophysiology
• Neural Circuits
• Social Behavior
• +۷ مورد دیگر

Dr. Allyson Friedman serves as an Associate Professor in the Department of Biological Sciences within Hunter College's School of Arts and Sciences at the City University of New York. She leads the Friedman Laboratory, which focuses on cellular neurophysiology and behavior research with significant contributions to understanding neural circuit mechanisms underlying social behaviors and affective disorders. Dr. Friedman's educational background includes: Postdoctoral Fellowship at Icahn School of Medicine at Mount Sinai Ph.D. from Mount Sinai School of Medicine of New York University B.A. from Barnard College, Columbia University Her research program investigates the neural circuits and neuroadaptations that mediate social behaviors, with particular emphasis on how affective disorders manifest as social dysfunction. The Friedman Laboratory explores how diverse coping strategies, sex hormones, and social support can induce changes in the underlying neural circuits guiding social behaviors. This research aims to identify beneficial and pathological neural adaptations that could lead to new therapeutic targets for mood and anxiety disorders. Dr. Friedman employs cutting-edge methodologies including cell-type/circuit specific in vitro electrophysiological recordings, viral-mediated gene transfer, and optogenetic manipulations in animal models to examine neural adaptations from the level of ion channels through to behavioral outcomes. Her publication record demonstrates consistent focus on stress response mechanisms, social behaviors, and mood disorders across multiple disciplines including neuroscience, psychiatry, pharmacology, and endocrinology. A recurring theme is the exploration of sex differences in neural responses to stress and their implications for affective disorders, with particular emphasis on the ventral tegmental area, amygdala, bed nucleus of stria terminalis, and related neural circuits. Her most recent work (2023) continues to advance understanding of how hormonal fluctuations influence neural excitability and social behavior under stress conditions. Dr. Friedman leads an active research laboratory at Hunter College with ongoing projects including 'Cell type specific mechanisms of stress adaptation in the bed nucleus of stria terminalis and the ventral tegmental area' and 'Neuropathophysiological Mechanisms of Premenstrual Dysphoric Disorder (PMDD).' Her laboratory appears to be well-integrated with the CUNY Neuroscience Collaborative and Hunter College's Biology department resources.

Brian Kavanaughمشاهده پروفایل

استادیار

• Clinical Neuropsychology
• Pediatric Neuropsychology
• Executive Functions
• +۵ مورد دیگر

Brian Kavanaugh is an Assistant Professor of Psychiatry and Human Behavior at Brown University's Alpert Medical School and a pediatric neuropsychologist at Bradley Hospital and Rhode Island Hospital. Board-certified in clinical neuropsychology with pediatric subspecialty certification from the American Board of Professional Psychology, he directs research at the intersection of neurodevelopment and psychiatric disorders in youth. His educational trajectory includes a BA from Loyola University (2009), PsyD in Clinical Psychology from Antioch University New England (2014), followed by pediatric neuropsychology fellowship training at E. P. Bradley Hospital and Brown University (2014-2016). Dr. Kavanaugh's research pioneers brain-based interventions for childhood neuropsychiatric disorders using multimodal neuroimaging (MRI), electrophysiology (EEG), and neuromodulation (TMS). His work targets executive dysfunction across diagnostic boundaries, with particular emphasis on oscillatory dynamics in working memory, genetic neurodevelopmental disorders (ASH1L, SLC13A5, Christianson syndrome), and trauma-related neurocognitive sequelae. He actively develops translational approaches to modulate neural circuits underlying cognitive deficits. Analysis of his 15 most recent publications (2023-2025) reveals dominant research streams: 1) Neural oscillation biomarkers for cognitive deficits in ADHD and depression, 2) Lifespan phenotyping of rare genetic disorders, 3) Sex-specific neurodevelopmental manifestations, and 4) TMS treatment optimization using neurophysiological predictors. His work consistently bridges basic neuroscience with clinical intervention. Scientific recognition includes: NIMH K23 Career Development Award Brain & Behavior Research Foundation NARSAD Young Investigator Award Current research funding spans NIMH, Brain & Behavior Research Foundation, The Carol Peterson Foundation, and the COBRE Center for Neuromodulation. While specific advisees aren't documented in source materials, his leadership in the COBRE Center involves mentoring junior investigators in pediatric neuromodulation. Collaborative networks include neurologists, geneticists, and psychiatrists across Brown's clinical ecosystem. Dr. Kavanaugh operates within the Division of Child and Adolescent Psychiatry, leveraging institutional resources at Bradley Hospital's Pediatric Neuropsychology Service and the COBRE Center for Neuromodulation. His team integrates clinical assessment with advanced neurophysiological methods to develop circuit-targeted interventions for youth with complex neuropsychiatric presentations.

Reed Selwynمشاهده پروفایل

استاد

• Diagnostic Medical Physics
• Radioactive Microspheres
• Imaging of Traumatic Brain Injury
• +۵ مورد دیگر

Dr. Reed Selwyn is a practicing, board-certified (ABR) diagnostic medical physicist at the University of New Mexico (UNM) School of Medicine, holding a Professor appointment with secondary roles as Chief of Imaging Medical Physics , Director of the Graduate Medical Physics Program , and Executive Vice Chair of Radiology . He is affiliated with the UNM School of Medicine, the Comprehensive Cancer Center, and Cancer Therapeutics. Specialization: Targeted radiomicrosphere therapy, PET/MRI neuroimaging, and radiation health physics Leadership: Former Training Director for Naval Nuclear Power Training Command, technical advisor for Fukushima nuclear accident Grants: $9M in DOD/NIH funding, including a $1.8M NIH S10 High-End Instrumentation grant Dr. Selwyn’s research focuses on PET-based dosimetry for liver cancer radiomicrosphere therapy and advanced neuroimaging for mild traumatic brain injury (mTBI). His lab collaborates with Chemical and Biological Engineering to develop novel resin and glass microspheres. Scientific Awards : Defense Meritorious Service Medal AAPM John R. Cameron Young Investigator Award UNM Regent’s Professor award Military commendations (multiple) He established the first Bruker 7T PET/MRI system in the U.S., launched a Human Imaging Research Core, and initiated a Medical Physics Outreach Program for underserved communities in New Mexico.

Sandy Shultzمشاهده پروفایل

استاد

• Traumatic Brain Injury
• Neurotrauma
• Concussion
• +۷ مورد دیگر

Sandy Shultz is a Professor and Group Leader in the Department of Neuroscience within the School of Translational Medicine at Monash University, based at the Van Cleef Centre for Nervous Diseases. His research is dedicated to understanding traumatic brain injury (TBI), concussion, and post-traumatic epilepsy, with a strong emphasis on pathophysiological mechanisms, biomarker discovery, and therapeutic development. His research interests center on traumatic brain injury , neuroinflammation , biomarkers , and translational neuroscience . He employs both preclinical rodent models and clinical studies to investigate the neurological consequences of trauma, including intimate partner violence-related brain injury and perinatal trauma. His work integrates neuroimaging, molecular biology, and behavioral analysis to uncover mechanisms and potential treatments. The recent articles highlight a consistent focus on TBI and its complications, including the impact of infections like Toxoplasma gondii on brain injury outcomes, structural brain changes in chronic TBI, and the development of diagnostic and rehabilitation strategies for concussion. These publications reflect a multidisciplinary approach spanning molecular, systems, and clinical neuroscience. He has received the Brain Foundation 2019 Research Gift for his contributions to neuroscience research. Sandy Shultz is actively involved in major research projects such as the SELECT Trial (sodium selenate for epilepsy), INFORMED (concussion management in sports), and NIH-funded initiatives on epilepsy therapy and biomarker discovery. These projects involve extensive collaboration with national and international researchers and institutions, underscoring his leadership in the field. He leads the Shultz Lab, a dynamic research group focused on advancing the understanding and treatment of nervous system injuries. The lab engages in both fundamental and applied research, contributing significantly to the field of translational medicine.

Karen Anthonyمشاهده پروفایل

استاد

• RNA processing
• Neuropathophysiology of Duchenne muscular dystrophy
• RNA-based gene therapy
• +۶ مورد دیگر

Professor Karen Anthony is Professor of Molecular Medicine at the University of Northampton within the School of Life and Environmental Science. She leads the Molecular Biosciences Research Group and maintains affiliations with the Centre for Physical Activity and Life Sciences and the Northamptonshire Dementia Research & Innovation Centre. Dr. Anthony teaches across multiple undergraduate programs including Biological Science, Biochemistry, Pharmacology and Biomedical Science, serving as Module Leader for Molecular and Cellular Neuroscience and contributing to the MSc in Molecular Medicine program. Her educational background includes: Master's degree and PGCert in Research Degree Supervision from the University of Northampton (2016-2017) PhD in 'tau RNA processing in neurodegeneration: trans-acting factors regulating alternative splicing and mRNA localisation' from King's College London (2005-2009) BSc (Hons) Biochemistry with medical biochemistry from the University of Leeds (2001-2005) City & Guilds licentiateship award in applied biochemistry from GlaxoSmithKline (2003-2004) Professor Anthony's research focuses on RNA processing and the pre-clinical development of RNA therapeutics for rare neurological diseases. Her work spans multiple areas including Duchenne muscular dystrophy neuropathophysiology, the DMD gene's role in cancer, RNA processing of dystrophin, therapeutic targeting of brain dystrophin, RNA processing in neurodegeneration, and RNA-based gene therapy. She has established proof-of-concept for RNA reprogramming strategies including trans-splicing therapies for spinocerebellar ataxia type 1 and tauopathies, building on her earlier contributions to the first FDA-approved drug for DMD. Her recent publications demonstrate a strong translational focus, bridging molecular biology with clinical applications across neurological disorders and cancer. The research shows increasing interdisciplinary collaboration, integrating molecular techniques with cognitive assessment, exercise physiology, and patient-centered interventions to address rare diseases from multiple angles. Professor Anthony actively consults for international pharmaceutical and biotechnology companies on clinical trial methodology and RNA therapeutic development. She has secured funding for eight major projects including the Northampton Advanced Imaging Facility and research on trans-splicing applications for rare diseases. Her work has contributed to the development of the first FDA-approved drug for Duchenne muscular dystrophy, demonstrating significant translational impact. She leads the Molecular Biosciences Research Group and is instrumental in developing the Northampton Advanced Imaging Facility (NAIF), which serves as a hub for flow cytometry and advanced imaging. Her team collaborates extensively with clinical researchers and industry partners to advance RNA therapeutics from bench to bedside, with particular focus on rare neurological conditions affecting both children and adults.

• Medical Sciences
• Pharmacology
• Epilepsy
• +۵ مورد دیگر

Monika Banach, MD, PhD is an Assistant Professor at the Faculty of Pharmacy, Medical University of Lublin , affiliated with the Independent Experimental Neuropathophysiology Unit. Her research focuses on medical sciences, particularly in pharmacology and neuropathophysiology. Education: Doctoral degree (2020) Research Interests: Monika specializes in drug therapy , epilepsy , and brain motor activity , utilizing animal models (e.g., mice) to study long-term behavioral outcomes. Her work intersects pharmacology, neuroscience, and experimental medicine. Awards & Achievements: Her career includes 1 documented achievement, though specific details are not provided in the text. Publications: Monika has authored or co-authored 38 publications, with research trends emphasizing drug synergism , epileptic seizures , and memory mechanisms in preclinical models.

• Neuroimmunology
• Neuro-infectious Diseases
• Long COVID
• +۷ مورد دیگر

Lindsay McAlpine, MD is an Assistant Professor in the Department of Neurology at Yale University School of Medicine, specializing in neuroimmunology and neuro-infectious diseases. She founded and directs the NeuroCOVID Clinic at Yale, which treats patients with persistent neurological symptoms following COVID-19 infection, including brain fog, headaches, neuropathy, and cognitive impairment. Her work bridges clinical care with cutting-edge research on the neurological consequences of viral infections. Dr. McAlpine received her medical degree from Sidney Kimmel Medical College at Thomas Jefferson University in 2017, completed her residency at Yale-New Haven Hospital in 2021, and finished her fellowship training at Yale University in 2023. Her educational background includes a BSc in Environmental Science from Brown University (2009) and a Post-Baccalaureate program at the University of California, Berkeley (2013). Her research focuses on understanding the neuropathophysiology of Long COVID using advanced imaging techniques, particularly MRI. She investigates how viral infections like SARS-CoV-2 trigger neuroinflammation and lead to persistent neurological symptoms. Her work spans multiple domains including cognitive neuroscience, cerebrovascular circulation, and autoimmune responses in the central nervous system. She employs a comprehensive approach that combines advanced neuroimaging, biomarker testing, and extensive neuropsychological assessments to understand damage to the central, autonomic, and peripheral nervous systems. Analysis of Dr. McAlpine's recent publications reveals a strong focus on the neurological manifestations of COVID-19, particularly small fiber neuropathy, cognitive impairment, and autonomic dysfunction. Her work demonstrates how advanced MRI techniques can identify biomarkers of cerebral dysfunction in patients with post-COVID cognitive impairment. She has also contributed to understanding the role of autoimmunity in Long COVID and investigated potential therapeutic approaches for post-viral neurological conditions. NIMH Grant to advance research into Long COVID and related brain changes (2025) Grant to investigate causes of post-COVID-19 neurologic condition (2024) Dr. McAlpine serves as a sub-investigator for multiple clinical trials related to Long COVID, including 'The Brain Shuttle Study' and research on brain fog in Long COVID patients. She leads the McAlpine Lab, which focuses on understanding the mechanisms that damage the nervous system after COVID-19. Her lab collaborates extensively with the Clinical Neurosciences Imaging Center (CNIC) and the Center for Infection & Immunity at Yale. The McAlpine Lab conducts research using advanced MRI techniques to study structural, vascular, and functional changes in the brains of Long COVID patients. The lab works with a team including postgraduate associates and collaborates with researchers across Yale University. They recruit research participants both locally and throughout the United States to better understand the impact of Long COVID on the nervous system.

• Neurodegenerative Diseases
• Traumatic Brain Injury
• Biomarkers
• +۷ مورد دیگر

Richard Rubenstein is a Professor in the Department of Neurology at SUNY Downstate Medical Center. His research spans over three decades, focusing on neurodegenerative disorders, traumatic brain injuries (TBI), and their long-term pathological consequences, including tauopathies and synucleinopathies. He integrates translational studies using in vitro, in vivo, and human patient models to advance biomarker discovery and diagnostic technologies. Education: BS - Brooklyn College MS - Brooklyn College PhD - New York University Post Doctorate - Memorial Sloan Kettering Cancer Center Dr. Rubenstein's laboratory investigates the neuropathophysiological mechanisms underlying TBI and its progression to diseases such as Alzheimer’s and chronic traumatic encephalopathy. His work emphasizes developing ultrasensitive diagnostic assays and neuroprotective therapies through pharmacological and molecular strategies. His research employs laser-based instrumentation and site-directed immunological reagents to detect biomarkers in the central nervous system (CNS) and biofluids, targeting disease diagnosis, prognosis, and therapeutic monitoring. This approach bridges basic science and clinical applications in neurology. For inquiries, he can be reached at richard.rubenstein@downstate.edu .

• Bipolar Disorder
• Mood Disorders
• Psychiatry
• +۵ مورد دیگر

Dr. Caleb M. Adler is a Professor of Psychiatry and Neuroscience at the University of Cincinnati College of Medicine. He serves as the Vice Chair of Clinical Research and is the co-director of the Division of Bipolar Disorders Research and Director of the Center for Imaging Research. Dr. Adler received his Bachelor's degree from Pennsylvania State University and his Medical Degree from Jefferson Medical College of the Thomas Jefferson University. He completed his residency in Psychiatry at Georgetown University Medical Center, where he was a Chief Resident, and a Senior Staff Fellowship in the Experimental Therapeutics Branch of the National Institute of Mental Health. He is certified by the American Board of Psychiatry and Neurology (Psychiatry), with certification dating back to March 31, 1998, and recertified through January 15, 2022. Dr. Adler's primary research focuses on the use of neuroimaging techniques to study both healthy cognitive processes and the neuropathophysiology of bipolar and psychotic disorders, as well as the psychopharmacologic treatment of bipolar disorder . His work spans multiple domains including bipolar disorder, mood disorders, neuroimaging, psychopharmacology, and major depressive disorder. Through his research, he has made significant contributions to understanding brain structure and function in bipolar disorder, particularly in adolescents and young adults. Analysis of Dr. Adler's recent publications reveals a strong emphasis on neuroimaging biomarkers in bipolar disorder, with particular focus on adolescent populations. His research consistently explores the intersection of brain structure/function, mood disorders, and pharmacological interventions, with growing interest in nutritional approaches and comorbid conditions like substance use disorders. Dr. Adler has received substantial research funding from prestigious sources including the National Institute of Mental Health, Theodore & Vada Stanley Foundation, National Alliance for Research on Schizophrenia and Affective Disorders, and various pharmaceutical companies. These grants total millions of dollars and support cutting-edge research in bipolar disorder treatment and neurobiology. As Vice Chair of Clinical Research and Director of the Center for Imaging Research, Dr. Adler leads a multidisciplinary team focused on advancing our understanding of mood disorders through innovative imaging techniques and clinical trials. His work has established the University of Cincinnati as a leading center for bipolar disorder research.

Sukhvir Wrightمشاهده پروفایل

پژوهشگر ارشد

• Neuro-immunological diseases
• Autoimmune encephalitis
• Epilepsy
• +۶ مورد دیگر

Sukhvir Wright is a Clinical Research Career Development Fellow at Aston University, affiliated with the Pharmacology & Translational Neuroscience Research Group (PTNRG) and the Aston Institute of Health & Neurodevelopment. She holds an honorary consultant position at Birmingham Children's Hospital. Her research focuses on neuro-immunological diseases in children, including autoimmune encephalitis, epilepsy, and multiple sclerosis. She employs electrophysiological techniques in rodent models to study autoantibody pathophysiology and evaluates advanced neuroimaging like MEG to predict clinical outcomes. Education: PhD in Autoimmune epilepsies and encephalopathies of childhood (University of Oxford, 2015), MBBS (Royal Free and University College Medical School, 2001), BSc in Physiology and Pharmacology (UCL, 1998). Research Projects: "The immune system and epilepsy" (Epilepsy Research UK) "Study of Neuronal Antibodies in Paediatric Epilepsy" (Wellcome Trust) "Predictors of cognitive recovery in paediatric immune-mediated encephalitis" (Encephalitis Society) Teaching: NE3001 Brain Disorders and Disease, IPP7 Independent Prescribing (Cranial Nerves). Her work bridges clinical practice and research, leading specialized NHS services for pediatric MS and advancing neurophysiological tools. Collaborations include studies on MEG in MOG-Ab disease and epilepsy priorities in the UK. Grants and Projects: Multiple funded initiatives from institutions like Epilepsy Research UK, Wellcome Trust, and Birmingham Women's and Children's Hospital Research Foundation. Supervised 2 doctoral works. Labs/Teams: PTNRG and collaborations with institutions like University College London and Oxford.

• Genetics
• Oncology
• Neurobiology
• +۳ مورد دیگر

Michael Naidoo is a researcher affiliated with the Centre for Physical Activity and Life Sciences, focusing on interdisciplinary research at the intersection of genetics, oncology, and neurobiology. His work explores the molecular basis of Duchenne Muscular Dystrophy (DMD) and its unexpected connections to cancer, particularly in context-dependent tumor suppression and oncogenicity. His research interests include: Duchenne Muscular Dystrophy and Dystrophin isoforms (e.g., Dp71) Gene expression dynamics in cancer IDH mutant low-grade glioma prognosis Neuropathophysiology and cell migration mechanisms Bulk RNA sequencing and survival trends in oncogenetics Michael’s publications highlight the dual role of the DMD gene in both neurological and oncological contexts, with a focus on molecular biomarkers. His work has been widely cited, appearing in high-impact journals like FEBS Open Bio and Scientific Reports , and has attracted significant attention on social media and in news outlets. He has presented his findings at academic conferences, including an oral presentation on dystrophin Dp71’s role in cell migration and cancer. His collaborations span institutions, with co-authorships on studies linking DMD to glioma prognosis and tumor biology.

Cory Whiteمشاهده پروفایل

پژوهشگر ارشد

• Neurovirology
• Neurochemistry
• Lipid Metabolism
• +۳ مورد دیگر

Cory White, PhD, is a Postdoctoral Fellow at Emory University, specializing in neurovirology, lipid metabolism, and HIV-associated neurocognitive disorders. He earned a BS in Biochemistry and Molecular Biology from Mercer University (2014) and a PhD in Biochemistry, Cellular & Molecular Biology from Johns Hopkins University (2021). Research Focus Dr. White investigates how neurovirulent infections like HIV and antiretroviral therapy (ART) alter brain lipid metabolism, focusing on fatty acid oxidation and spatial lipid distribution in animal models and human tissue. His work bridges biochemistry, neurology, and virology. Scientific Awards & Honors NIH Loan Repayment Program contract (2022) NINDS BRAINS Fellow (2022) Rockefeller University Exceptional Scholar (2022) NIH Blueprint Diversity Fellowship (2020) Spotlight Article & Cover, Molecular and Cellular Biology (2020) NSF Graduate Research Fellowship Honorable Mention (2016)

• Cognitive Neuroscience
• Autism Spectrum Disorder
• Substance Use Disorders
• +۵ مورد دیگر

Dr Natalia Albein-Urios is a Visiting Professor at Deakin University's School of Psychology , affiliated with the SEED - Lifespan strategic research center. Her work bridges Cognitive Neuroscience and Clinical Psychology , focusing on Autism Spectrum Disorder (ASD) and Substance Use Disorders (SUD) via Non-invasive Brain Stimulation (NIBS) , fMRI , and EEG . Education : PhD in Neuropsychology (Summa Cum Laude, University of Granada, 2012), Master in Health Psychology (University Miguel Hernandez, 2007), International Master in Clinical Psychology (Spanish Association of Behavioural Psychology, 2009), and BAppSc (Hons) in Psychology (University of Miguel Hernandez, 2007). Research Interests center on: Neurocognitive Mechanisms in ASD and SUD Non-invasive Brain Stimulation (HD-tDCS, TMS, TBS) Neuroimaging (fMRI, EEG) and Behavioral Interventions Emotion Regulation and Executive Dysfunction Her Recent Publications highlight advancements in: Transdiagnostic Approaches to mental health via computational modeling Brain Stimulation Efficacy in ASD and addiction Neuroimaging Biomarkers for dual disorders Scientific Awards include: Best Thesis Prize in Health Sciences, University of Granada (2016) Health Research Postdoctoral Fellowship , Deakin University (2015-2017) First Prizes for Best Poster (ECNP 2018) and Oral Presentation (ICDBMD 2011) Supervision spans 14 Honours Students since 2015 and PhD students like Gillian Clark (2017) and Dinisha Parmar (2021). She has secured grants such as the Research Development Grant (Deakin University, 2014). Her work contributes to the SEED - Lifespan team's mission in translational neuroscience.

Cal Adlerمشاهده پروفایل

استاد

• Psychiatry
• Neuroimaging
• Bipolar Disorder
• +۲ مورد دیگر

Cal Adler is a Professor of Psychiatry and Neuroscience at the University of Cincinnati College of Medicine. He serves as Vice Chair of Clinical Research and Director of the Center for Imaging Research. His work focuses on neuroimaging techniques to investigate healthy cognitive processes and the neuropathophysiology of bipolar and psychotic disorders, with a particular emphasis on psychopharmacologic treatments. B.S., Pennsylvania State University M.D., Thomas Jefferson University Psychiatry Residency, Georgetown University Medical Center Experimental Therapeutics Fellowship, National Institute of Mental Health Research Interests: Dr. Adler specializes in neuroimaging studies of bipolar disorder, including longitudinal analyses of brain structure/function, medication response mechanisms, and risk prediction models for youth offspring of bipolar parents. His work bridges psychiatric neurobiology with advanced imaging modalities like fMRI, MRS, and DTI. Publication Trends: His articles (2015-2021) focus on Neurochemical alterations in bipolar disorder Predictive modeling of treatment response Brain connectivity in mood episodes Lithium and antipsychotic effects Cortical thickness and white matter integrity AI applications in neurotrauma outcomes Scientific Awards: None explicitly listed in the text. Grants: Major funding includes NIH grants (K23, R01, ARRA supplements) for studies on neuroimaging markers of bipolar treatment response, glutamatergic neurotransmission, and multimodal imaging in adolescent mania. He has also received private foundation support from the National Alliance for Research on Schizophrenia and Affective Disorders.